Cargando…

Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein

This study aimed to investigate whether the anti-tumor effect of gemcitabine (GEM) in non-small-cell lung cancer (NSCLC) treatment was affected by Danggui Buxue decoction (DBD), and explore the potential mechanisms. The combined use of GEM and DBD showed an enhanced tumor growth inhibition effect in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiyang, Xu, Xin, Chen, Yanfei, Guan, Rong, Cheng, Tingting, Wang, Ye, Jin, Rui, Song, Min, Hang, Taijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572355/
https://www.ncbi.nlm.nih.gov/pubmed/31130654
http://dx.doi.org/10.3390/molecules24102011
_version_ 1783427621338480640
author Sun, Xiyang
Xu, Xin
Chen, Yanfei
Guan, Rong
Cheng, Tingting
Wang, Ye
Jin, Rui
Song, Min
Hang, Taijun
author_facet Sun, Xiyang
Xu, Xin
Chen, Yanfei
Guan, Rong
Cheng, Tingting
Wang, Ye
Jin, Rui
Song, Min
Hang, Taijun
author_sort Sun, Xiyang
collection PubMed
description This study aimed to investigate whether the anti-tumor effect of gemcitabine (GEM) in non-small-cell lung cancer (NSCLC) treatment was affected by Danggui Buxue decoction (DBD), and explore the potential mechanisms. The combined use of GEM and DBD showed an enhanced tumor growth inhibition effect in a murine Lewis lung carcinoma (LLC) model. LC-MS/MS results showed that the pharmacokinetic behaviors of a GEM active metabolite, gemcitabine triphosphate (dFdCTP), were found to be altered remarkably in the peripheral blood mononuclear cells (PBMC) of DBD co-administration rats. In addition, after co-administration of DBD with GEM, Western Blot and qPCR results confirmed that the expression of deoxycytidine kinase (dCK) in tumor tissues of LLC-bearing mice were markedly increased. DBD co-administration also reversed the upregulation of P-glycoprotein (P-gp) in tumor tissues induced by GEM. Moreover, DBD could notably up-regulate the IL-12p70 and GM-CSF expression in mice serum, suggesting potential immunomodulatory activities in tumor-bearing mice. Meanwhile, DBD inhibited the P-gp efflux activity in A549 cells. Therefore, the regulation of dCK and P-gp played important roles in the alternation of GEM pharmacokinetics and the enhancement of the anti-tumor effect of GEM. DBD being a potential dCK promoter could work as an adjuvant agent to boost the anticancer effect of GEM.
format Online
Article
Text
id pubmed-6572355
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65723552019-06-18 Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein Sun, Xiyang Xu, Xin Chen, Yanfei Guan, Rong Cheng, Tingting Wang, Ye Jin, Rui Song, Min Hang, Taijun Molecules Article This study aimed to investigate whether the anti-tumor effect of gemcitabine (GEM) in non-small-cell lung cancer (NSCLC) treatment was affected by Danggui Buxue decoction (DBD), and explore the potential mechanisms. The combined use of GEM and DBD showed an enhanced tumor growth inhibition effect in a murine Lewis lung carcinoma (LLC) model. LC-MS/MS results showed that the pharmacokinetic behaviors of a GEM active metabolite, gemcitabine triphosphate (dFdCTP), were found to be altered remarkably in the peripheral blood mononuclear cells (PBMC) of DBD co-administration rats. In addition, after co-administration of DBD with GEM, Western Blot and qPCR results confirmed that the expression of deoxycytidine kinase (dCK) in tumor tissues of LLC-bearing mice were markedly increased. DBD co-administration also reversed the upregulation of P-glycoprotein (P-gp) in tumor tissues induced by GEM. Moreover, DBD could notably up-regulate the IL-12p70 and GM-CSF expression in mice serum, suggesting potential immunomodulatory activities in tumor-bearing mice. Meanwhile, DBD inhibited the P-gp efflux activity in A549 cells. Therefore, the regulation of dCK and P-gp played important roles in the alternation of GEM pharmacokinetics and the enhancement of the anti-tumor effect of GEM. DBD being a potential dCK promoter could work as an adjuvant agent to boost the anticancer effect of GEM. MDPI 2019-05-25 /pmc/articles/PMC6572355/ /pubmed/31130654 http://dx.doi.org/10.3390/molecules24102011 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sun, Xiyang
Xu, Xin
Chen, Yanfei
Guan, Rong
Cheng, Tingting
Wang, Ye
Jin, Rui
Song, Min
Hang, Taijun
Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein
title Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein
title_full Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein
title_fullStr Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein
title_full_unstemmed Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein
title_short Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein
title_sort danggui buxue decoction sensitizes the response of non-small-cell lung cancer to gemcitabine via regulating deoxycytidine kinase and p-glycoprotein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572355/
https://www.ncbi.nlm.nih.gov/pubmed/31130654
http://dx.doi.org/10.3390/molecules24102011
work_keys_str_mv AT sunxiyang dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein
AT xuxin dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein
AT chenyanfei dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein
AT guanrong dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein
AT chengtingting dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein
AT wangye dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein
AT jinrui dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein
AT songmin dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein
AT hangtaijun dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein